Achaogen (AKAO) Set to Announce Earnings on Thursday

Achaogen (NASDAQ:AKAO) will be posting its quarterly earnings results before the market opens on Thursday, November 8th. Analysts expect Achaogen to post earnings of ($0.96) per share for the quarter.

Achaogen (NASDAQ:AKAO) last issued its earnings results on Monday, August 6th. The biopharmaceutical company reported ($1.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.19). The firm had revenue of $2.56 million during the quarter, compared to analyst estimates of $1.49 million. Achaogen had a negative return on equity of 146.50% and a negative net margin of 2,286.21%. On average, analysts expect Achaogen to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Shares of AKAO stock opened at $3.25 on Wednesday. The stock has a market capitalization of $169.08 million, a PE ratio of -1.03 and a beta of 0.67. The company has a quick ratio of 3.79, a current ratio of 3.79 and a debt-to-equity ratio of 0.42. Achaogen has a 1-year low of $3.20 and a 1-year high of $15.00.

Several equities research analysts have recently weighed in on AKAO shares. Cowen reissued a “buy” rating on shares of Achaogen in a research note on Friday, July 27th. Stifel Nicolaus increased their price target on Achaogen from $14.00 to $22.00 and gave the company a “buy” rating in a research note on Tuesday, August 7th. Zacks Investment Research raised Achaogen from a “sell” rating to a “hold” rating in a research note on Friday, August 3rd. BidaskClub cut Achaogen from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 18th. Finally, Needham & Company LLC cut Achaogen from a “buy” rating to a “hold” rating in a research note on Tuesday, August 7th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $14.81.

WARNING: “Achaogen (AKAO) Set to Announce Earnings on Thursday” was first reported by WKRB News and is the sole property of of WKRB News. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at

About Achaogen

Achaogen, Inc, a late-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin for the treatment of serious bacterial infections, including urinary tract infections, blood stream infections, and other infections due to MDR enterobacteriaceae comprising carbapenem-resistant enterobacteriaceae.

Featured Article: Why do companies issue stock splits?

Earnings History for Achaogen (NASDAQ:AKAO)

Receive News & Ratings for Achaogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achaogen and related companies with's FREE daily email newsletter.

Leave a Reply